US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

158.18

-0.3650-0.23%

Volume:6.62M

Turnover:1.05B

Market Cap:41.87B

PE:-11.13

High:158.50

Open:158.01

Low:157.31

Close:158.54

52wk High:160.59

52wk Low:127.35

Shares:264.72M

Float Shares:264.72M

Volume Ratio:1.28

T/O Rate:2.50%

Dividend:2.48

Dividend Rate:1.57%

EPS(TTM):-14.2170

EPS(LYR):-14.2170

ROE:-9.22%

ROA:1.03%

PB:1.22

PE(LYR):-11.13

Loading ...

Overview Company News Filings

VR-CARES Study Shows How Virtual Reality Could Reshape Caregiver Support and Healthcare Ecosystems

Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments

Exchange-Traded Funds Mixed, Equity Futures Higher Pre-Bell Tuesday Amid AI Disruption Fears

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Janux Therapeutics Inc (JANX) and CVS Health (CVS)

Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

Septerna to Present at TD Cowen 46th Annual Health Care Conference

Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference

Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

Sell Rating on Fresenius Medical Care Amid Unsustainable Earnings Quality and Structural Headwinds

Is It Time To Reassess Tenet Healthcare (THC) After Its 3 Year Share Price Surge?

Simply Wall St.

Morgan Stanley Remains a Buy on ConvaTec (CTEC)

Legend Biotech: Undervalued BCMA CAR-T Leader with Lower Commercial Risk and DCF-Supported Upside to $50 Target

Quadria-Led Consortium Completes $470 Million Take-Private of Apex Healthcare

Hextar Healthcare Malaysia 4th-Quarter 2025 Earnings Summary Table

EPF Increases Substantial Stake in IHH Healthcare to 12.85%

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (VIR) and Summit Therapeutics (SMMT)

Health Care Roundup: Market Talk

Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT) and Community Health (CYH)

Oppenheimer Sticks to Its Buy Rating for Prestige Consumer Healthcare (PBH)

Barclays Remains a Sell on Organon (OGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XLV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"Health Care Select Sector SPDR Fund","latestPrice":158.175,"timestamp":1771952218808,"preClose":158.54,"halted":0,"volume":6615336,"delay":0,"changeRate":-0.00230225810520992,"floatShares":264715324,"shares":264715324,"eps":-14.217021,"marketStatus":"Trading","change":-0.365,"latestTime":"02-24 11:56:59 EST","open":158.01,"high":158.5,"low":157.3075,"amount":1045482012.25104,"amplitude":0.007522,"askPrice":158.18,"askSize":100,"bidPrice":158.17,"bidSize":320,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":158.54,"sharesOutstanding":264715324,"nav":156.768162,"aum":41498934785.52,"dividendRate":0.015665,"bidAskSpread":0.000078,"preHourTrading":{"tag":"盘前","latestPrice":158.25,"preClose":158.54,"latestTime":"09:28 EST","volume":2236,"amount":354434.88912,"timestamp":1771943328458,"change":-0.29,"changeRate":-0.001829,"amplitude":0.005385},"postHourTrading":{"tag":"盘后","latestPrice":158.7601,"preClose":158.54,"latestTime":"19:59 EST","volume":1245138,"amount":197441833.0009,"timestamp":1771894783081,"change":0.2201,"changeRate":0.001388,"amplitude":0.002334},"volumeRatio":1.282647,"impliedVol":0.1756,"impliedVolPercentile":0.5339},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":264715324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":1.282647,"shares":264715324,"dividePrice":2.4778,"high":158.5,"amplitude":0.007522,"preClose":158.54,"low":157.3075,"week52Low":127.35,"pbRate":"1.22","psRate":"63.57","week52High":160.59,"institutionHeld":0.7846,"latestPrice":158.175,"committee":0.52381,"eps":-14.217021,"divideRate":0.015665,"volume":6615336,"delay":0,"ttmEps":-14.217021,"open":158.01,"prevYearClose":154.8,"prevWeekClose":156.82,"prevMonthClose":154.74,"prevQuarterClose":154.8,"fiveDayClose":157.37,"twentyDayClose":158.1,"sixtyDayClose":158.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XLV","amount":0.564539,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XLV","amount":0.621655,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.236696,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.285214,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614465367","title":"VR-CARES Study Shows How Virtual Reality Could Reshape Caregiver Support and Healthcare Ecosystems","url":"https://stock-news.laohu8.com/highlight/detail?id=2614465367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614465367?lang=en_us&edition=fundamental","pubTime":"2026-02-25 00:31","pubTimestamp":1771950716,"startTime":"0","endTime":"0","summary":"Trane Technologies Plc ($TT) announced an update on their ongoing clinical study. The VR-CARES study, officially titled “VR-CARES: Feasibility of V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vr-cares-study-shows-how-virtual-reality-could-reshape-caregiver-support-and-healthcare-ecosystems?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vr-cares-study-shows-how-virtual-reality-could-reshape-caregiver-support-and-healthcare-ecosystems?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","VR","BK4588","BK4585","BK4581","LABU","HCSG","BK4137","XBI","XLV"],"gpt_icon":0},{"id":"2613101547","title":"Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2613101547","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613101547?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:15","pubTimestamp":1771942500,"startTime":"0","endTime":"0","summary":"Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptomsZORYVE (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243707/0/en/Professional-Golfer-Max-Homa-Joins-Arcutis-Free-to-Be-Me-Campaign-Urging-Individuals-with-Seborrheic-Dermatitis-to-Tee-Up-a-Conversation-with-Their-Healthcare-Provider-About-Long-T.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4137","LU0029874061.USD","BK4581","LU0128526141.USD","XBI","XLV","HCSG","LABU","BK4588"],"gpt_icon":0},{"id":"2613465712","title":"Exchange-Traded Funds Mixed, Equity Futures Higher Pre-Bell Tuesday Amid AI Disruption Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2613465712","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613465712?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:52","pubTimestamp":1771941171,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.02% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% higher in Tuesday's premarket activity amid concerns around t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XSD","OWL","IGV","AMD.AU","TNC.AU","XLF","VHT","RTH.AU","IYH","IYW","BETH","RTH","UNG","SPY","VDC","IGM","EQR","IYJ","EEM","XLY","VHT.AU","VIS","IVV","XLE","XRT","SOXX","XLI",".DJI","AMD","HD","SPY.AU","FAS","FMS.AU","XLV","CEG","TNC","EETH","IYK","XLK","BITO","IYE","FMS","IBB","XLP","FAZ"],"gpt_icon":1},{"id":"2613717809","title":"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Janux Therapeutics Inc (JANX) and CVS Health (CVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613717809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613717809?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:50","pubTimestamp":1771941010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD – Research Report), Janux Ther...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-janux-therapeutics-inc-janx-and-cvs-health-cvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-janux-therapeutics-inc-janx-and-cvs-health-cvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LU0234570918.USD","GILD","LU2468319806.SGD","LU2324357040.USD","LU0128526141.USD","LU0070302665.USD","LU0109394709.USD","LU1674673428.USD","LU1571399168.USD","LU0162691827.USD","LU0122379950.USD","HCSG","LU0432979614.USD","LU0823416689.USD","BK4585","IE00B19Z3B42.SGD","JANX","BK4137","LU0208291251.USD","LU0965508806.USD","LU1699723380.USD","BK4196","LU0965509010.AUD","LU1023059063.AUD","LU1061106388.HKD","IE00B3T34201.USD","LU0114720955.EUR","LABU","BK4578","IE00BSNM7G36.USD","BK4539","LU0320765992.SGD","LU1839511570.USD","SG9999015986.USD","BK4532","CVS","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4504","LU0965509101.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0061475181.USD","LU1430594728.SGD","LU0889565916.HKD","LU0211331839.USD","BK4550","LU1983299246.USD"],"gpt_icon":0},{"id":"2613714472","title":"Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714472","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714472?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938000,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Feb.  24, 2026  (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243524/0/en/Acrivon-Therapeutics-to-Present-at-the-TD-Cowen-46th-Annual-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4127","BK4588","BK4139","TD","BK4539","BK4207","COWN","LENZ","XBI","BK4581","XLV","BK4007","BK4566"],"gpt_icon":0},{"id":"2613714407","title":"Septerna to Present at TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714407","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714407?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb.  24, 2026   -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  drug discovery, announced that Jeffrey Finer, M.D., Ph.D., chief executive officer and co-founder of Septerna, will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 3:10 p.m. ET in Boston. A live webcast of the presentation will be available in the investors section of the company’s website at www.septerna.com. The webcast will be archived for at least 30 days following the presentation. About SepternaSepterna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company’s proprietary Native Complex Platform is designed to enable new approaches to GPCR drug discovery and has led to the development of a diverse pipeli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243503/0/en/Septerna-to-Present-at-TD-Cowen-46th-Annual-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","SEPN","TD","BK4585","BK4007","LABU","BK4588","XLV","BK4207","XBI","BK4127","BK4566","BK4599","COWN","GPCR"],"gpt_icon":0},{"id":"2613719397","title":"Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719397","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719397?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934400,"startTime":"0","endTime":"0","summary":"NEW YORK and WALTHAM, Mass., Feb.  24, 2026  (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243371/0/en/Dianthus-Therapeutics-to-Participate-in-The-TD-Cowen-46th-Annual-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4207","BK4581","TD","BK4566","LABU","LENZ","XBI","BK4539","BK4588","COWN","BK4585","XLV","BK4007","BK4127"],"gpt_icon":0},{"id":"2613560719","title":"Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613560719","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613560719?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:00","pubTimestamp":1771934400,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J. and SUZHOU, China, Feb.  24, 2026  (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (\"Transcenta Therapeutics\"), a global clinical stage biopharmaceutical company with full","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243379/0/en/Transcenta-Therapeutics-to-Present-at-the-36th-Annual-Oppenheimer-Healthcare-Life-Sciences-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0128526141.USD","BK4539","LU0029874061.USD","XBI","BK4137","BK4585","BK4007","BK4588","OPY","LENZ","LABU","BK4139","XLV","HCSG","BK4127"],"gpt_icon":0},{"id":"2613971569","title":"Sell Rating on Fresenius Medical Care Amid Unsustainable Earnings Quality and Structural Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2613971569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613971569?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:55","pubTimestamp":1771934146,"startTime":"0","endTime":"0","summary":"Fresenius Medical Care AG & Co. KGaA, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Anna Ractliffe from Bank...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sell-rating-on-fresenius-medical-care-amid-unsustainable-earnings-quality-and-structural-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sell-rating-on-fresenius-medical-care-amid-unsustainable-earnings-quality-and-structural-headwinds-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","XBI","BK4581","XLV"],"gpt_icon":0},{"id":"2613716527","title":"Is It Time To Reassess Tenet Healthcare (THC) After Its 3 Year Share Price Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2613716527","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613716527?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:23","pubTimestamp":1771932217,"startTime":"0","endTime":"0","summary":"If you are wondering whether Tenet Healthcare's current share price lines up with its underlying value, this article is designed to walk you through that question step by step.\nTenet Healthcare's stock last closed at US$233.77, with returns of 1.2% over 7 days, 23.8% over 30 days, 17.2% year to date, 77.7% over 1 year and 299.3% over 3 years. These figures can change how investors think about both upside and risk.\nRecent news around Tenet Healthcare has focused on its role in the US hospital...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/is-it-time-to-reassess-tenet-healthcare-thc-after-its-3-year","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/is-it-time-to-reassess-tenet-healthcare-thc-after-its-3-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0963586101.USD","LU1201861165.SGD","BK4588","THC.AU","BK4585","BK4581","LU0130103400.USD","BK4185","LABU","LU0648000940.SGD","LU2324357040.USD","XBI","DCF","THC","XLV"],"gpt_icon":0},{"id":"2613189067","title":"Morgan Stanley Remains a Buy on ConvaTec (CTEC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613189067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613189067?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:18","pubTimestamp":1771931883,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Aisyah Noor maintained a Buy rating on ConvaTec today and set a price target of p270.00. Noor covers the Healthcare sector, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-convatec-ctec-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-convatec-ctec-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1363072403.SGD","LU1791710582.SGD","LU0106831901.USD","LU2271345857.HKD","LU0882574139.USD","LU0098860793.USD","LU1720051108.HKD","BK4588","LU0795875169.SGD","BK4534","LU2111349929.HKD","LU1244550221.USD","LU1732799900.SGD","LU1732800096.USD","LU1720051017.SGD","LU1244550494.USD","LU1989772840.SGD","LU0158827781.USD","LU1791710400.SGD","BK4581","LU1162221912.USD","LU0234570918.USD","LU2347655156.SGD","LU1668664300.SGD","LU0225283273.USD","IE00BKVL7J92.USD","LU0106261372.USD","CTEC","LU0158827948.USD","LU1244550577.SGD","XBI","LU2357305700.SGD","BK4127","LU0912757837.SGD","BK4516","LU1989772923.USD","LU1548497426.USD","LU2023251221.USD","LU1074936037.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","XLV","LU2133065610.SGD","LU2089284900.SGD","LU0320765646.SGD","BK4585","LU2089283258.USD","LU0528227936.USD","BK4504","LABU"],"gpt_icon":0},{"id":"2613910718","title":"Legend Biotech: Undervalued BCMA CAR-T Leader with Lower Commercial Risk and DCF-Supported Upside to $50 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2613910718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613910718?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:16","pubTimestamp":1771931776,"startTime":"0","endTime":"0","summary":"Legend Biotech, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mitchell Kapoor from H.C. Wainwright reiterate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/legend-biotech-undervalued-bcma-car-t-leader-with-lower-commercial-risk-and-dcf-supported-upside-to-50-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/legend-biotech-undervalued-bcma-car-t-leader-with-lower-commercial-risk-and-dcf-supported-upside-to-50-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","LABU","DCF","XBI","BK4581","LEGN","BK4139","BK4585","BK4588","BK4230","CAR","BK4022","XLV"],"gpt_icon":0},{"id":"2613945087","title":"Quadria-Led Consortium Completes $470 Million Take-Private of Apex Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2613945087","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613945087?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:55","pubTimestamp":1771926900,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--A consortium led by Asian private-equity firm Quadria Capital has taken a major Malaysian pharmaceutical company private in the latest sign of deal momentum in the region.Quadria, which manages $4.2 billion in assets, said it completed the take-private acquisition of Apex Healthcare on Tuesday.The deal values Apex, which makes pharmaceuticals, consumer healthcare products and medical devices, at about $470 million.Quadria said the transaction is the largest of its kind in the Southeast Asia healthcare space in the past five years and biggest ever in Malaysia.Investor caution amid uncertainty over global trade policy has weighed on private-equity investments over the past year, but Asia-Pacific is still viewed as a region of long-term opportunity thanks to a diverse mix of mature markets and fast-growing emerging economies, said Andrew Thompson at KPMG.While overall deal values remain subdued, there are signs that volumes are stabilizing and valuations resetting ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4137","BK4581","XLV","LU0128526141.USD","BK4585","HCSG","LABU","LU0029874061.USD"],"gpt_icon":0},{"id":"2613279451","title":"Hextar Healthcare Malaysia 4th-Quarter 2025 Earnings Summary Table","url":"https://stock-news.laohu8.com/highlight/detail?id=2613279451","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613279451?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:52","pubTimestamp":1771926720,"startTime":"0","endTime":"0","summary":"Figures Are In Ringgit (MYR).Revenue                      35,536,000         41,654,000. PreTax Profit               -21,211,000        -10,634,000. Net Profit                  -31,386,000         -7,990,000. Earnings Per Share            -2.85 Sen          -0.76 Sen. Dividend                       0.00 Sen           0.00 Sen. Revenue                     148,114,000        146,950,000. PreTax Profit               -37,480,000        -18,981,000. Net Profit                  -44,956,000        -13,920,000. Earnings Per Share            -4.08 Sen          -1.33 Sen. Dividend                       0.00 Sen           0.00 Sen. Copyright (c) 2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","XLV"],"gpt_icon":0},{"id":"2613794404","title":"EPF Increases Substantial Stake in IHH Healthcare to 12.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613794404","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613794404?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:44","pubTimestamp":1771926264,"startTime":"0","endTime":"0","summary":"The latest update is out from IHH Healthcare Bhd ( ($IHHHF) ). Employees Provident Fund Board, a substantial shareholder in IHH Healthcare Berhad, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-increases-substantial-stake-in-ihh-healthcare-to-12-85?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-increases-substantial-stake-in-ihh-healthcare-to-12-85?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","HCSG","LU0128526141.USD","BK4581","XBI","BK4137","XLV","LABU","LU0029874061.USD"],"gpt_icon":0},{"id":"2613879447","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (VIR) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613879447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613879447?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:40","pubTimestamp":1771926008,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vir Biotechnology (VIR – Research Report) and Summit Therapeutics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-vir-biotechnology-vir-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-vir-biotechnology-vir-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","LU0128526141.USD","LU0029874061.USD","VIR","LU2488822045.USD","BK4588","BK4585","BK4581","BK4568","LABU","SMMT","HCSG","BK4137","BK4139","XBI","XLV"],"gpt_icon":0},{"id":"2613799108","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2613799108","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613799108?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:20","pubTimestamp":1771924800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0728 GMT - Novo Nordisk's miss of a key goal in a late-stage comparison clinical trial of obesity drug CagriSema with Eli Lilly's Zepbound is a blow to the Danish drugmaker's long-term outlook, Citi analysts say. CagriSema is Novo Nordisk's next-generation product intended to fill the gap left by the patent expiration of semaglutide, the key ingredient behind blockbuster obesity and diabetes drugs Wegovy and Ozempic, according to Citi. The drug failed to show noninferior weight loss compared to market leader Zepbound and this, together with higher manufacturing complexity, makes it less likely to compete effectively, the analysts say. Citi cuts its target price on Novo Nordisk to 309 Danish kroner from 340 kroner. Shares closed 16% lower at 251.40 kroner on Monday. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NVOX","LABU","LU0154236417.USD","BK4007","BK4581","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","LU1093756325.SGD","XBI","NVO","LU1093756168.USD","BK4588","NVOH","XLV"],"gpt_icon":1},{"id":"2613486799","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT) and Community Health (CYH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613486799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613486799?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:00","pubTimestamp":1771923620,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Summit Therapeutics (SMMT – Research Report) and C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-summit-therapeutics-smmt-and-community-health-cyh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-summit-therapeutics-smmt-and-community-health-cyh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","CYH","LU0029874061.USD","LU2488822045.USD","BK4185","SMMT","BK4588","BK4137","BK4139","LU0128526141.USD","XBI","BK4581","HCSG","XLV"],"gpt_icon":0},{"id":"2613796287","title":"Oppenheimer Sticks to Its Buy Rating for Prestige Consumer Healthcare (PBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796287","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613796287?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:56","pubTimestamp":1771923366,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Rupesh Parikh from Oppenheimer maintained a Buy rating on Prestige Consumer Healthcare. The company’s shares closed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-prestige-consumer-healthcare-pbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-prestige-consumer-healthcare-pbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","OPY","XLV","PBH"],"gpt_icon":0},{"id":"2613796231","title":"Barclays Remains a Sell on Organon (OGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613796231?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:47","pubTimestamp":1771922844,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo maintained a Sell rating on Organon today and set a price target of $8.00. Santangelo covers the Healthcare sector...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-organon-ogn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-organon-ogn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","BK4585","BK4007","LU2065169927.USD","BK4588","LU2065170008.USD","OGN","BK4559","LABU","XBI","BK4581","LU2065171311.SGD","XLV"],"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":1,"totalSize":322,"code":"91000000","status":"200"}]}}